Elsemieke Passchier

2PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jul 03, 2024
Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0.

Chilam Chan, J H Marco Jansen, Ilona S T Hendriks

|Feb 12, 2024
MUC13 negatively regulates tight junction proteins and intestinal epithelial barrier integrity via protein kinase C.

Celia Segui-Perez, Daphne A C Stapels, Ziliang Ma

Pageof 1

Frequent Collaborators

1 joint publications

Chilam Chan

1 joint publications

J H Marco Jansen

1 joint publications

Ilona S T Hendriks

1 joint publications

Ida C van der Peet

1 joint publications

Meggy E L Verdonschot

1 joint publications

Maria Tsioumpekou

1 joint publications

Maaike Nederend

1 joint publications

Sharon A Klomp

1 joint publications

Thomas Valerius

1 joint publications

Matthias Peipp

Frequent Collaborators

1 joint publications

Chilam Chan

1 joint publications

J H Marco Jansen

1 joint publications

Ilona S T Hendriks

1 joint publications

Ida C van der Peet

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.5K
<em>In Vitro</em> and <em>In Vivo </em>Approaches to Determine Intestinal Epithelial Cell Permeability
10:22

<em>In Vitro</em> and <em>In Vivo </em>Approaches to Determine Intestinal Epithelial Cell Permeability

Published on : Oct 19, 2018

25.5K
See more related videos

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.5K
<em>In Vitro</em> and <em>In Vivo </em>Approaches to Determine Intestinal Epithelial Cell Permeability
10:22

<em>In Vitro</em> and <em>In Vivo </em>Approaches to Determine Intestinal Epithelial Cell Permeability

Published on : Oct 19, 2018

25.5K
See more related videos